surescan microarray scanner laser reader (Agilent technologies)
90
Structured Review
Agilent technologies
surescan microarray scanner laser reader
Surescan Microarray Scanner Laser Reader, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/surescan+microarray+scanner+laser+reader/pm38801463-54-16-22
Average 90 stars, based on 1 article reviews
Surescan Microarray Scanner Laser Reader, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/surescan+microarray+scanner+laser+reader/pm38801463-54-16-22
Average 90 stars, based on 1 article reviews
surescan microarray scanner laser reader - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Fluorescence:Article Title: Potential molecular patterns for tuberculosis susceptibility in diabetic patients with poor glycaemic control: a pilot study. Article Snippet: Type 2 diabetes (DM2) is an increasingly prevalent disease that challenges tuberculosis (TB) control strategies worldwide.. It is significant that DM2 patients with poor glycemic control (PDM2) are prone to developing tuberculosis.. Furthermore, elucidating the molecular mechanisms that govern this susceptibility is imperative to address this problem. Microarray:Article Title: Potential molecular patterns for tuberculosis susceptibility in diabetic patients with poor glycaemic control: a pilot study. Article Snippet: Type 2 diabetes (DM2) is an increasingly prevalent disease that challenges tuberculosis (TB) control strategies worldwide.. It is significant that DM2 patients with poor glycemic control (PDM2) are prone to developing tuberculosis.. Furthermore, elucidating the molecular mechanisms that govern this susceptibility is imperative to address this problem. Extraction:Article Title: Potential molecular patterns for tuberculosis susceptibility in diabetic patients with poor glycaemic control: a pilot study. Article Snippet: Type 2 diabetes (DM2) is an increasingly prevalent disease that challenges tuberculosis (TB) control strategies worldwide.. It is significant that DM2 patients with poor glycemic control (PDM2) are prone to developing tuberculosis.. Furthermore, elucidating the molecular mechanisms that govern this susceptibility is imperative to address this problem. |